Lin Shi

422 total citations
25 papers, 311 citations indexed

About

Lin Shi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lin Shi has authored 25 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Lin Shi's work include Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (6 papers) and MicroRNA in disease regulation (5 papers). Lin Shi is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (6 papers) and MicroRNA in disease regulation (5 papers). Lin Shi collaborates with scholars based in China, Hong Kong and United States. Lin Shi's co-authors include Bin Ke, Yuanyuan Huang, Shaobing Chen, Siyun Wang, Weiliang Zhu, Lin Zhuo, Bei Zhang, Xiaoting Chen, Gang Wu and Junfang Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Medicine and World Journal of Gastroenterology.

In The Last Decade

Lin Shi

22 papers receiving 309 citations

Peers

Lin Shi
Leiming Wang China
Yifan Zeng China
Shamin Rezaei Iran
Elahe Sadat Hejazi Iran
Zining Jin China
Paul Allegakoen United States
Zhigang Cao China
Michael D. Arensman United States
Leiming Wang China
Lin Shi
Citations per year, relative to Lin Shi Lin Shi (= 1×) peers Leiming Wang

Countries citing papers authored by Lin Shi

Since Specialization
Citations

This map shows the geographic impact of Lin Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Shi more than expected).

Fields of papers citing papers by Lin Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Shi. The network helps show where Lin Shi may publish in the future.

Co-authorship network of co-authors of Lin Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Shi. A scholar is included among the top collaborators of Lin Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Shi. Lin Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duan, Yuting, et al.. (2025). Incomplete reporting and spin in acupuncture randomised controlled trials: a cross-sectional meta-epidemiological study. BMJ evidence-based medicine. 30(4). bmjebm–2024.
2.
3.
4.
X, Li, Lin Shi, Chunyan Wang, et al.. (2024). Volatile organic compounds in exhaled breath: a promising approach for accurate differentiation of lung adenocarcinoma and squamous cell carcinoma. Journal of Breath Research. 18(4). 46007–46007. 2 indexed citations
5.
6.
Shi, Lin, et al.. (2023). Alleviation of Angiotensin II-Induced Vascular Endothelial Cell InjuryThrough Long Non-coding RNA TUG1 Inhibition. Combinatorial Chemistry & High Throughput Screening. 27(10). 1523–1532. 3 indexed citations
7.
Wu, Yuan, Xuefeng Zhou, Weiqing Zhao, et al.. (2023). Therapeutic effectiveness of anlotinib combined with etoposide in extensive-stage small-cell lung cancer: a single-arm, phase II trial. Investigational New Drugs. 41(6). 825–833. 2 indexed citations
8.
Shi, Lin, Yuanyuan Huang, Shaobing Chen, et al.. (2023). Circ_0003028 enhances the proliferation and glycolytic capacity and suppresses apoptosis in non-small cell lung cancer cells via the miR-1305/miR-1322-SLC5A1 axis. Annals of Translational Medicine. 11(5). 215–215. 6 indexed citations
9.
Shi, Lin, et al.. (2023). An integrative pan-cancer analysis illustrating the key role of LRP11 in cervical cancer. Medicine. 102(11). e33201–e33201. 4 indexed citations
10.
Li, Xian, Ma Yongxiang, Guosheng Xing, et al.. (2022). Lentivirus-mediated short hairpin RNA interference of CENPK inhibits growth of colorectal cancer cells with overexpression of Cullin 4A. World Journal of Gastroenterology. 28(37). 5420–5443. 3 indexed citations
11.
Shi, Lin, Weiliang Zhu, Yuanyuan Huang, et al.. (2022). Cancer‐associated fibroblast‐derived exosomal microRNA‐20a suppresses the PTEN/PI3K‐AKT pathway to promote the progression and chemoresistance of non‐small cell lung cancer. Clinical and Translational Medicine. 12(7). e989–e989. 123 indexed citations
12.
Shi, Lin, Han Wang, Wei Yang, Andrew Z. Wang, & Cuizhi Geng. (2020). Silencing of Long Non-Coding RNA Colon Cancer-Associated Transcript 2 Inhibits the Growth and Metastasis of Gastric Cancer Through Blocking mTOR Signaling. SHILAP Revista de lepidopterología. 1 indexed citations
13.
14.
Zhou, Guoren, et al.. (2020). TFAP2A Induced ITPKA Serves as an Oncogene and Interacts with DBN1 in Lung Adenocarcinoma. International Journal of Biological Sciences. 16(3). 504–514. 29 indexed citations
15.
Shi, Lin, et al.. (2019). IL‐7–Mediated IL‐7R‐JAK3/STAT5 signalling pathway contributes to chemotherapeutic sensitivity in non–small‐cell lung cancer. Cell Proliferation. 52(6). e12699–e12699. 13 indexed citations
16.
17.
Ke, Bin, et al.. (2018). Flavored Guilu Erxian decoction inhibits the injury of human bone marrow mesenchymal stem cells induced by cisplatin. Cellular and Molecular Biology. 64(6). 58–64. 10 indexed citations
18.
Shi, Lin, et al.. (2017). Up-regulation of miR-146a increases the sensitivity of non-small cell lung cancer to DDP by downregulating cyclin J. BMC Cancer. 17(1). 138–138. 45 indexed citations
19.
Shi, Lin, et al.. (2016). Application of Visual Interactive Concept Map in College English Writing Teaching. International Journal of Emerging Technologies in Learning (iJET). 11(11). 32–32. 6 indexed citations
20.
Shi, Lin. (2012). Exploring clinical efficacy of Fructus Amomi. Zhonghua zhongyiyao zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leiming Wang Breakdown of academic impact, for papers by Yifan Zeng Breakdown of academic impact, for papers by Shamin Rezaei Breakdown of academic impact, for papers by Elahe Sadat Hejazi Breakdown of academic impact, for papers by Zining Jin Breakdown of academic impact, for papers by Paul Allegakoen Breakdown of academic impact, for papers by Zhigang Cao Breakdown of academic impact, for papers by Michael D. Arensman
Rankless by CCL
2026